Technical Analysis for MBIO - Mustang Bio, Inc.
|Grade||Last Price||% Change||Price Change|
MBIO closed down 4.32 percent on Wednesday, April 25, 2018, on 76 percent of normal volume. Note that the stock is in oversold territory based on its Slow Stochastic indicator (14, 3, 3) -- sideways movement or a bounce should not be unexpected.
|Weak or Absent||N/A||Down||Down|
|See historical MBIO trend table...|
|Date||Alert Name||Type||% Chg|
|Apr 25||Lower Bollinger Band Walk||Weakness||0.00%|
|Apr 25||Stochastic Reached Oversold||Weakness||0.00%|
|Apr 25||Below Lower BB||Weakness||0.00%|
|Apr 25||Down 3 Days in a Row||Weakness||0.00%|
|Apr 25||Down 4 Days in a Row||Weakness||0.00%|
|Apr 25||Down 5 Days in a Row||Weakness||0.00%|
|Apr 25||Lower Bollinger Band Touch||Weakness||0.00%|
|Apr 25||Oversold Stochastic||Weakness||0.00%|
|Apr 24||Lower Bollinger Band Walk||Weakness||-4.32%|
|Apr 24||Below Lower BB||Weakness||-4.32%|
Get this analysis on your stocks daily!
Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicatorsBasic chart:
Mustang Bio, Inc. is a clinical-stage biopharmaceutical company. The Company is focused on the development and commercialization of cancer immunotherapy products designed to utilize the power of the patient’s own immune system to eliminate cancer cells. It seeks to acquire rights to technologies by licensing or otherwise acquiring an ownership interest in the technologies, funding their research and development and eventually either out-licensing or bringing the technologies to market. The Company is developing its proprietary Chimeric Antigen Receptor (CAR) engineered T cells (CAR -T) technology, which uses the patient’s own T cells to engage and destroy specific tumors. The Company, through its agreement with City of Hope National Medical Center, is using three novel CAR T therapies in the development of cancer treatments, including human epidermal growth factor receptor 2 CAR T technology, CS1-specific CAR T technology, and prostate stem cell antigen CAR T technology.
|Indicator||Bull Case||Neutral / Hold||Bear Case|
|Oversold / Overbought|
|Summary:||Counts: 0 bullish, 2 bearish and 3 neutral indicators. You may wish to incorporate that into your trading strategies.|
See more MBIO news...
|52 Week High||13.35|
|52 Week Low||8.055|
|200-Day Moving Average||0.0|
|50-Day Moving Average||10.7564|
|20-Day Moving Average||10.207|
|10-Day Moving Average||9.86|
|Average True Range||0.5967|
|Chandelier Exit (Long, 3 ATRs )||9.7099|
|Chandelier Exit (Short, 3 ATRs )||10.5701|
|Upper Bollinger Band||11.3467|
|Lower Bollinger Band||9.0673|
|Percent B (%b)||-0.09|
|MACD Signal Line||-0.3193|
|Pivot Point Level||Traditional / Classic||Fibonacci||Demark||Woodie||Camarilla|
|Resistance 4 (R4)||9.76|
|Resistance 3 (R3)||9.83||9.61||9.61|
|Resistance 2 (R2)||9.61||9.38||9.57||9.56|
|Resistance 1 (R1)||9.23||9.24||9.12||9.16||9.51|
|Support 1 (S1)||8.63||8.78||8.52||8.56||8.21|
|Support 2 (S2)||8.41||8.64||8.37||8.16|
|Support 3 (S3)||8.03||8.41||8.11|
|Support 4 (S4)||7.96|